Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer — Stella

Recruiting

Back to Ovarian Cancer trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

Brigham and Women's Hospital, Boston, Massachusetts

Dana Farber Cancer Institute, Boston, Massachusetts

Key details

Phase

Early testing

Sponsor

Brigham and Women's Hospital

Collaborators

National Cancer Institute (NCI), Dana-Farber Cancer Institute

Enrollment target

~20 participants

Started

November 2022

Primary completion

June 2026

Age range

18 Years and older

Sex

Female only

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov